NCT00544180TerminatedPhase 4
Record on Satisfaction of Patients With Actonel 35 mg Once a Week
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 4
- Status
- Terminated
- Sponsor
- Sanofi
- Enrollment
- 7
- Locations
- 2
- Primary Endpoint
- Patient satisfaction and compliance
Study Overview
Brief Summary
To determine the satisfaction of subject with Actonel 35 mg Once a Week in the treatment of post-menopausal osteoporosis. Open, non-controlled, multi-center study.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 55 Years to 80 Years (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Patient satisfaction and compliance
Time Frame: During all the study
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Completed
Phase 4
Risedronate Sodium in Post Menopausal OsteoporosisOsteoporosis, PostmenopausalNCT00453492Sanofi246
Completed
Not Applicable
Assessment of the Satisfaction of Patient Undergoing Opioid Replacement Therapy Toward Their Management in Community PharmacyOpioid-Related DisordersNCT03961789University Hospital, Clermont-Ferrand98
Completed
Not Applicable
Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular RiskErectile DysfunctionNCT00874185Pfizer's Upjohn has merged with Mylan to form Viatris Inc.720
Completed
Not Applicable
Patient Satisfaction in Cutaneous SurgerySkin CancerNCT01535963Northwestern University354
Unknown
Not Applicable
Same day discHarge aftEr Laparoscopic hysTERectomy (SHELTER trial)Total laparoscopic hysterectomy, benign indication, discharge.<br />Totale laparoscopische hysterectomie, benigne indicNL-OMON21121Maxima Medical Centre100